At what gestational age is diclofenac contraindicated during pregnancy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 19, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Diclofenac Contraindication in Pregnancy

Diclofenac should be avoided at approximately 30 weeks gestation and later in pregnancy, with cautious use and limited duration between 20-30 weeks gestation. 1

Gestational Age-Specific Recommendations

At 30 Weeks and Beyond: Absolute Avoidance

The FDA drug label explicitly states to avoid diclofenac potassium use at about 30 weeks gestation and later in pregnancy due to the increased risk of premature closure of the fetal ductus arteriosus 1. This represents a hard contraindication based on the mechanism of NSAID action on prostaglandin synthesis.

Between 20-30 Weeks: Use Only If Essential

Starting at approximately 20 weeks gestation, diclofenac carries significant risks and should only be used if absolutely necessary:

  • Limit to lowest effective dose and shortest duration possible
  • If treatment extends beyond 48 hours, ultrasound monitoring for oligohydramnios is recommended
  • Discontinue immediately if oligohydramnios develops 1

The rationale: NSAIDs at this stage can cause fetal renal dysfunction leading to oligohydramnios and potential neonatal renal impairment 1.

Key Fetal Risks by Timing

Third Trimester (≥27 weeks):

  • Premature closure of ductus arteriosus
  • Persistent pulmonary hypertension in the newborn
  • Oligohydramnios from fetal renal dysfunction
  • Maternal vaginal bleeding (diclofenac specifically associated with 1.8-fold increased risk) 2

Second Trimester: Research shows diclofenac use in the second trimester was significantly associated with low birthweight (adjusted OR 3.1) 2, and a 2025 cohort study identified diclofenac as one of the NSAIDs with elevated CKD risk when used in the second trimester 3.

Clinical Context

The older 2009 guideline suggested avoiding NSAIDs in "the last six to eight weeks of pregnancy" 4, but the current FDA labeling provides more specific and conservative guidance at 30 weeks 1. This reflects updated understanding of fetal risks, particularly regarding ductus arteriosus constriction and renal effects.

Important Caveats:

  • These restrictions apply to systemic diclofenac (oral, intramuscular, intravenous routes)
  • The mechanism involves prostaglandin inhibition affecting fetal cardiovascular and renal development
  • Individual NSAIDs may have slightly different risk profiles, but diclofenac specifically has been associated with maternal bleeding complications in late pregnancy 2

Bottom line: Hard stop at 30 weeks, extreme caution with monitoring between 20-30 weeks, and consider alternative analgesics (acetaminophen) throughout pregnancy when possible.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.